Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Caitlin E. Cox

December 11, 2019

News Conference News AHA 2019

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

Yael L. Maxwell

November 21, 2019

News Daily News

Noninvasive Tests for Chest Pain: New Insight Into Who Benefits Most

Yael L. Maxwell

November 07, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Conference News ESC 2019

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

Caitlin E. Cox

September 06, 2019

News Conference News ESC 2019

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

Michael O'Riordan

September 05, 2019

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

News Daily News

A Boost for Prescription Omega-3s? Not Yet: FDA Panel Set for November

Yael L. Maxwell

August 14, 2019

News Conference News SCCT 2019

Chest Pain Rule-Out? For Two ED Scores, It’s a Draw

Yael L. Maxwell

July 19, 2019

News Daily News

Microvascular Disease Quadruples Risk of Leg Amputation

L.A. McKeown

July 08, 2019

News Daily News

Vitamin D for CV Risk? Think Twice, Meta-analysis Confirms

Marcus A. Banks

June 21, 2019

News Conference News SCAI 2019

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Yael L. Maxwell

May 24, 2019

News Daily News

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

Yael L. Maxwell

May 15, 2019

News Daily News

No Need for Niacin? Meta-analysis Argues the End Is Nigh

Yael L. Maxwell

April 22, 2019

News Daily News

Zero CAC Reliably Excludes CAD Among Stable, Symptomatic Patients, but Experts Debate Its Need

Yael L. Maxwell

April 18, 2019

News Daily News

Initiative Helps Low-Resource Chinese Hospitals Provide Better ACS Care

L.A. McKeown

April 17, 2019

News Conference News ACC 2019

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

Yael L. Maxwell

March 22, 2019

News Daily News

Abnormal Coronary Reactivity in Women Portends Added CV, Death Risk in the Next Decade

Caitlin E. Cox

February 13, 2019

Advertisement

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

Noninvasive Tests for Chest Pain: New Insight Into Who Benefits Most

Recurrent Events Common Among Young Patients With CAD

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

A Boost for Prescription Omega-3s? Not Yet: FDA Panel Set for November

Chest Pain Rule-Out? For Two ED Scores, It’s a Draw

Microvascular Disease Quadruples Risk of Leg Amputation

Vitamin D for CV Risk? Think Twice, Meta-analysis Confirms

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Residual Inflammatory Risk and PCI: Worthy Biomarker or Merely Something Else to Measure?

No Need for Niacin? Meta-analysis Argues the End Is Nigh

Zero CAC Reliably Excludes CAD Among Stable, Symptomatic Patients, but Experts Debate Its Need

Initiative Helps Low-Resource Chinese Hospitals Provide Better ACS Care

REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events

Abnormal Coronary Reactivity in Women Portends Added CV, Death Risk in the Next Decade

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content